"Futuremeds tworzy sieć nowoczesnych przychodni zajmujących się prowadzeniem badań klinicznych. Naszym priorytetem jest bezpieczeństwo i zdrowie pacjentów. Prowadzimy programy bezpłatnych badań i konsultacji, dzięki czemu pacjenci mają łatwy dostęp do wczesnej diagnostyki, a po spełnieniu odpowiednich kryteriów i wyrażeniu zgody mogą wziąć udział w prowadzonych przez nas badaniach klinicznych zyskując szansę na skorzystanie z najnowocześniejszych leków oraz terapii. Działamy zgodnie ze standardami Dobrej Praktyki Klinicznej GCP i nieustannie się rozwijamy, aby zapewnić naszym pacjentom jak najlepszą opiekę. Nasz zespół tworzą profesjonaliści doświadczeni w prowadzeniu badań klinicznych."

During the past decade, Futuremeds sp. z o.o conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Futuremeds sp. z o.o" #1 sponsor was "Averitas Pharma, Inc." with 1 trials, followed by "Bayer" with 1 trials sponsored, "Ionis Pharmaceuticals, Inc." with 1 trials sponsored, "Janssen Research & Development, LLC" with 1 trials sponsored and "Pfizer" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

According to Clinical.Site data, the most researched conditions in "Futuremeds sp. z o.o" are "Crohn's Disease" (1 trials), "Neuropathic Pain Associated With Diabetic Peripheral Neuropathy" (1 trials), "Nonalcoholic Fatty Liver Disease" (1 trials), "Nonalcoholic Steatohepatitis With Liver Fibrosis" (1 trials) and "Post Surgical Neuropathic Pain" (1 trials). Many other conditions were trialed in "Futuremeds sp. z o.o" in a lesser frequency.

Most popular intervention types in "Futuremeds sp. z o.o" are "Drug" (5 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "BAY1817080" (1 trials), "Guselkumab" (1 trials), "Guselkumab Dose 1" (1 trials) and "Guselkumab Dose 2" (1 trials). Other intervention names were less common.

The vast majority of trials in "Futuremeds sp. z o.o" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Futuremeds sp. z o.o". undefined are not yet recruiting, 2 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Futuremeds sp. z o.o, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Futuremeds sp. z o.o, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".